Dirk Elston to Cost-Benefit Analysis
This is a "connection" page, showing publications Dirk Elston has written about Cost-Benefit Analysis.
Connection Strength
0.311
-
Letter from the Editor: Cost-effectiveness of tuberculosis screening in patients already on biologic therapy. J Am Acad Dermatol. 2022 10; 87(4):747-748.
Score: 0.168
-
Quality measures: do they really measure quality? Cutis. 2010 Jul; 86(1):8-10.
Score: 0.074
-
Comparative effectiveness research: get to know the term. Cutis. 2009 Jun; 83(6):287-8.
Score: 0.068